Healthcare Sales & Marketing Network News: low back pain

Searching News Database: low back pain

HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 17 Jul 2019
FDA Clears Erchonia's FX 635 for Relief of Chronic Musculoskeletal Pain
Devices FDA

HSMN NewsFeed - 11 Apr 2019
Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patients
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 18 Sep 2018
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 27 Aug 2018
SI-BONE, Inc. Announces France's National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System(R) for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 26 Jun 2018
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Jan 2018
SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Oct 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 26 Sep 2017
DiscGenics Raises $14 Million in Series B Financing
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 11 Jul 2017
Stryker's MultiGen(R) 2 Radiofrequency Generator Receives FDA 510(k) Clearance
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 13 Jun 2017
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System(R)
Devices Neurosurgery Orthopaedic Product Launch

HSMN NewsFeed - 12 Jun 2017
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement

HSMN NewsFeed - 8 May 2017
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement

HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 21 Jul 2016
Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT(R) for the Relief of Chronic Low Back Pain
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 15 Jun 2016
Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System(R) for SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 11 Feb 2016
SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 2 Nov 2015
SI-BONE, Inc.(R) Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 14 Oct 2015
Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 24 Mar 2015
Zyga Technology Announces Launch and First Commercial Use of Updated SImmetry(R) Sacroiliac Joint Fusion System
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 9 Mar 2015
SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 17 Feb 2015
Simplify Medical Announces CE Mark for New MRI Compatible Cervical Artificial Disc
Devices Orthopaedic Radiology Regulatory

HSMN NewsFeed - 28 Apr 2014
SI-BONE, Inc. Closes $33 Million Growth Capital Financing
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Mar 2014
Mainstay Medical Begins Clinical Trial of ReActiv8(R) for People with Chronic Low Back Pain
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 6 Jan 2014
SI-BONE, Inc. Announces 10,000 Procedure Milestone
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 6 Dec 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology

HSMN NewsFeed - 1 Aug 2013
Intrinsic Therapeutics Announces the Enrollment of the 400th Patient in Landmark Barricaid(R) Randomized Trial
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 19 Jul 2013
Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
Devices Neurology

HSMN NewsFeed - 18 Jul 2013
Spinal Restoration, Inc. Announces Disappointing Phase III Study Results for the Biostat(R) System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 1 Mar 2013
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Devices Orthopaedic

HSMN NewsFeed - 8 Jan 2013
Neurodevice Firm SPR(TM) Therapeutics Raises $5M Series A
Devices Neurology Venture Capital

HSMN NewsFeed - 22 Oct 2012
Spinal Restoration, Inc. Closes $5 Million Equity and Debt Financing Round
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 25 Jul 2012
Neurotech(R) Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain
Devices Orthopaedic

HSMN NewsFeed - 18 Jul 2012
Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro�s Chronic Pain Treatment
Devices

HSMN NewsFeed - 7 Nov 2011
Abbott Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals

HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Aug 2011
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 8 Aug 2011
Relievant Medsystems Receives FDA Approval to Begin Pivotal Study to Evaluate the Intracept System for Minimally Invasive Treatment of Chronic Low Back Pain
Devices FDA

HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA

HSMN NewsFeed - 23 May 2011
St. Jude Medical Announces Australian Market Launch for First-of-Its-Kind Neurostimulation Lead Delivery System for Chronic Pain
Devices

HSMN NewsFeed - 24 Mar 2011
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology Pain Management FDA

HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology

HSMN NewsFeed - 2 Dec 2010
St. Jude Medical Announces New Approvals of Five-Column Neurostimulation Lead to Manage Chronic Pain at 14th Annual North American Neuromodulation Society Meeting
Devices Neurology Regulatory

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Mar 2010
Spinal Restoration Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System
Devices Orthopaedic

HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
Devices

HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals

HSMN NewsFeed - 24 Jun 2009
Dynatronics Begins Shipping New V-Force Vibration Therapy Units
Devices

HSMN NewsFeed - 9 Jun 2009
Spinal Restoration Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 3 Jun 2009
CE Mark Extended for Disc Dynamics' DASCOR Disc Arthroplasty System
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 28 Apr 2009
ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
Devices Orthopaedic Regenerative Medicine FDA

HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management

HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2008
Medtronic Launches Discyphor Direct(TM) Catheter System
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 25 Jun 2008
TranS1 Inc. Announces the First Patients Treated With Its Percutaneous Nucleus Replacement, PNR, in Europe
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals

HSMN NewsFeed - 13 May 2008
Spinal Restoration, Inc. Receives FDA IDE Approval
Devices Neurosurgery Orthopaedic FDA

HSMN NewsFeed - 8 May 2008
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals

HSMN NewsFeed - 19 Feb 2008
NeuroMetrix and Cyberkinetics Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology

HSMN NewsFeed - 19 Feb 2008
Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology

HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology

HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology

HSMN NewsFeed - 7 Nov 2007
Axiom Worldwide's International Medical Advisory Board Steering Committee Issues Consensus Statement Regarding the Axiom Protocols!
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 1 Nov 2007
Biovail Launches Ralivia(TM) to Canadian Physicians
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 16 Oct 2007
Kyphon Stockholders Approve Merger with Medtronic
Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2007
Medtronic and Kyphon Announce Clearances in Spain, Austria and Cyprus for the Merger of Medtronic and Kyphon
Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Biopharmaceuticals Pain Mangement FDA

HSMN NewsFeed - 9 Oct 2007
Amicable Settlement Reached Between Axiom Worldwide and Adagen Medical
Devices Orthopaedic Litigation

HSMN NewsFeed - 9 Oct 2007
Spinal Restoration, Inc. Closes $16 Million Series B Financing
Devices Neurosurgery Orthopaedic Venture Capital

HSMN NewsFeed - 19 Sep 2007
Medtronic and Kyphon Announce Clearance from German Federal Cartel Office for the Merger of Medtronic and Kyphon
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Federal Trade Commission Clears Kyphon's Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
Devices Neurosurgery Orthopaedic Acquisitions

HSMN NewsFeed - 11 Sep 2007
Medtronic and Kyphon Announce Early Termination of Hart-Scott-Rodino Waiting Period for the Merger of Medtronic and Kyphon
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 7 Sep 2007
Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 27 Jul 2007
Medtronic to Acquire Kyphon for $3.9 Billion
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 12 Jul 2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 10 Jul 2007
Spinal Restoration and Baxter Announce Agreement for Developing Spinal Disc Application
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 18 Jun 2007
Medtronic Receives FDA Approval for New Tripolar, 16-Electrode Neurostimulation Lead to Treat Chronic Pain
Devices FDA

HSMN NewsFeed - 18 Jun 2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 May 2007
SpinalMotion's Kineflex(R) Artificial Lumbar Disc Long-Term Data Presented at International Spine Meeting
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 1 May 2007
Spinal Restoration Announces Clinical, Scientific and Business Advisory Boards
Devices Orthopaedic Personnel

HSMN NewsFeed - 9 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Mar 2007
Spinal Restoration, Inc. Names Gary E. Sabins as President and CEO
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 15 Feb 2007
St. Jude Medical Announces FDA Clearance of Spinal Cord Stimulation Leads for Patients with Low Back Pain
Devices Neurology FDA

HSMN NewsFeed - 18 Jan 2007
Kyphon Closes Acquisition of St. Francis Medical Technologies
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 15 Jan 2007
Kyphon and the Functional Anaesthetic Discography(TM) Procedure to be Featured on American Health Radio on Monday, January 15, 2007
Devices Orthopaedic

HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Dec 2006
Kyphon Signs Definitive Agreements to Acquire All Spine-Related Assets of Disc-O-Tech Medical Technologies
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 4 Dec 2006
Kyphon Signs Definitive Agreement to Acquire St. Francis Medical Technologies
Devices Neurosurgery Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 25 Oct 2006
NeuroMetrix, Inc. Signs Exclusive Licensing Agreement with EyeTel Imaging, Inc. for the Detection of Diabetic Retinopathy
Devices Ophthalmology Licensing

HSMN NewsFeed - 23 Oct 2006
First Patient Enrolled in Medtronic's Clinical Trial of the DIAM Spinal Stabilization System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 13 Oct 2006
Surgical Specialty Hospital of Arizona is First U.S. Center to Offer Treatment with the DASCOR(TM) Disc Arthroplasty System
Devices Orthopaedic

HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
Study Shows PRODISC(R)-L Total Disc Replacement is Effective, Safe Alternative to Spinal Fusion
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 27 Sep 2006
FDA Approves Clinical Trial For Medtronic's DIAM Spinal Stabilization System
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 27 Sep 2006
SpinalMotion Closes Series C Funding, Raises $20 Million
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 26 Sep 2006
Kyphon to Showcase Continued Product Innovation at 21st Annual Meeting of North American Spine Society
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 25 Sep 2006
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Oncology Drug Delivery FDA

HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 17 Aug 2006
Endo Comments on Recent Announcement by Penwest Pharmaceuticals, Its Development Partner on Opana(R) ER
Biopharmaceuticals

HSMN NewsFeed - 16 Aug 2006
FDA Approves ProDisc-L for Treatment of Low Back Pain
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 24 Jul 2006
Endo Announces Commercial Availability of Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate-Release Tablets CII
Biopharmaceuticals

HSMN NewsFeed - 13 Jul 2006
Milestone Scientific Receives 510(k) Premarket Notification Acceptance From FDA for CompuFlo(TM) Computer Controlled Infusion Pump
Devices FDA

HSMN NewsFeed - 10 Jul 2006
FDA Approves Clinical Trial for Medtronic's DIAM(TM) Spinal Stabilization System
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 5 Jul 2006
Four-Year Follow-up Study Shows Intermediate Term Efficacy of New Minimally Invasive X STOP Procedure for Common Cause of Low Back Pain
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 29 Jun 2006
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 28 Jun 2006
Spine Wave Begins Patient Enrollment in NuCore(TM) Injectable Nucleus Degenerative Disc Disease Feasibility Study
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 23 Jun 2006
Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate Release Tablets CII
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2006
Study Finds New Minimally Invasive X STOP Procedure Significantly More Effective Than Current Therapies for Common Cause of Low Back Pain
Devices Neurosurgery

HSMN NewsFeed - 19 May 2006
Spine Surgeons Dr. Adelt and Dr. Bertagnoli Present Follow Up Data On Patients Receiving the coflex(TM) Interspinous Implant
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 17 May 2006
Raymedica(R) Ten Year PDN(R) Prosthetic Disc Nucleus Clinical Results Presented at Major Spine Scientific Meeting
Devices Orthopaedic

HSMN NewsFeed - 9 May 2006
SpinalMotion Reports Significant Progress on Artificial Disc Clinical Trials
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 9 May 2006
Paradigm Spine Completes $14 Million Private Placement
Devices Venture Capital

HSMN NewsFeed - 9 May 2006
FDA Approves 'IDE' Clinical Trial of Paradigm Spine's Coflex(TM) Functionally Dynamic Interspinous Implant
Devices FDA Neurosurgery Orthopaedic

HSMN NewsFeed - 4 May 2006
Cephalon's Fentanyl Effervescent Buccal Tablet Reduces Intensity of Breakthrough Pain in Cancer Patients
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 4 May 2006
Oxymorphone Studies Presented at American Pain Society Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 24 Apr 2006
DOV Pharmaceutical, Inc. Announces Results for the First Phase III Trial of Bicifadine in Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 24 Apr 2006
St. Francis Medical Technologies Announces National Availability of First and Only FDA Approved, Non-Fusion Treatment for Common Degenerative Spine Disorder
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 14 Feb 2006
Orthogen AG: New Osteoarthritis Therapy Approved in the EU
Biopharmaceuticals Orthopaedic Regenerative Medicine

HSMN NewsFeed - 2 Feb 2006
DOV Pharmaceutical, Inc. Announces Completion of Enrollment in its Phase III Clinical Trial of Bicifadine in Chronic Low Back Pain
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2006
INFUSE(R) Bone Graft/LT-CAGE(R) Lumbar Tapered Fusion Device Approved for Use in Australia
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 4 Jan 2006
Kyphon Announces Definitive Agreement to Acquire InnoSpine, Inc.
Devices Orthopaedic Mergers & Acquisitions

Return to NewsFeed

Additional items found! 49

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 49 additional stories matching:
low back pain
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.